Dark
Streaming/Mobile
OldĀ Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
23:07:55 EDT Fri 11 Jul 2025
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:TYRA
- TYRA BIOSCIENCES INC -
Website unknown - click to update
23:07:55 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
TYRA
- Q
1.0
9.12
·
13.00
0.1
10.26
+0.02
0.2
211.1
2,053
2,625
10.14
10.58
9.965
29.60 6.42
16:04:13
Jul 08
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Down
-- UPC Restricted:
No
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - Last 10 of 2625
More trades...
Time ET
Ex
Price
Change
Volume
16:04:13
Q
10.26
0.02
1
16:02:00
Q
10.26
0.02
766
16:01:57
Q
10.26
0.02
161
16:01:44
Q
10.26
0.02
776
16:01:34
Q
10.26
0.02
106
16:01:22
Q
10.26
0.02
200
16:00:12
Q
10.26
0.02
51
16:00:12
Q
10.26
0.02
2
16:00:12
Q
10.26
0.02
473
16:00:00
Q
10.26
0.02
663
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2025-07-08 16:05
U:TYRA
News Release
200
Tyra Biosciences Announces Late-Breaking Poster Presentation on TYRA-300 Preclinical Results at ENDO 2025
2025-06-30 08:00
U:TYRA
News Release
200
Tyra Biosciences Doses First Patient in Phase 2 Study of TYRA-300 in Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (SURF302)
2025-05-12 16:05
U:TYRA
News Release
200
Tyra Biosciences to Participate at Upcoming Investor Conferences
2025-05-08 16:05
U:TYRA
News Release
200
Tyra Biosciences Reports First Quarter 2025 Financial Results and Highlights
2025-03-27 16:05
U:TYRA
News Release
200
Tyra Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights
2025-02-11 16:05
U:TYRA
News Release
200
Tyra Biosciences to Present at Upcoming Investor Conferences
2025-01-29 16:05
U:TYRA
News Release
200
Tyra Biosciences Announces Appointment of Adele Gulfo to Board of Directors
2025-01-22 08:00
U:TYRA
News Release
200
Tyra Biosciences Announces Poster Presentations at 2025 ASCO Gastrointestinal Cancers Symposium
2025-01-10 08:00
U:TYRA
News Release
200
Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Non-Muscle Invasive Bladder Cancer (SURF302)
2024-11-13 16:05
U:TYRA
News Release
200
Tyra Biosciences to Present at Upcoming Investor Conferences
2024-11-07 16:05
U:TYRA
News Release
200
Tyra Biosciences Reports Third Quarter 2024 Financial Results and Highlights
2024-10-28 07:00
U:TYRA
News Release
200
Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Pediatric Achondroplasia (BEACH301)
2024-10-24 18:05
U:TYRA
News Release
200
Tyra Biosciences Reports Interim Clinical Proof-of-Concept Data for TYRA-300, an Investigational Oral FGFR3-Selective Inhibitor, in Phase 1/2 SURF301 Study in Patients with Metastatic Urothelial Cancer (mUC)
2024-10-23 16:05
U:TYRA
News Release
200
Tyra Biosciences to Host Conference Call on Interim Clinical Data of TYRA-300 from SURF301 Phase 1/2 Study on October 25, 2024, at 8am ET
2024-10-11 08:00
U:TYRA
News Release
200
Tyra Biosciences Announces Late-Breaking Oral Presentation on Preliminary Safety and Anti-Tumor Activity of TYRA-300 from SURF301 at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2024)
2024-09-11 16:05
U:TYRA
News Release
200
Tyra Biosciences to Present at the 2024 Cantor Global Healthcare Conference
2024-09-10 16:05
U:TYRA
News Release
200
Tyra Biosciences Appoints Doug Warner, M.D., as Chief Medical Officer
2024-08-07 16:05
U:TYRA
News Release
200
Tyra Biosciences Reports Second Quarter 2024 Financial Results and Highlights